camostat has been researched along with paroxetine in 1 studies
*Paroxetine: A serotonin uptake inhibitor that is effective in the treatment of depression. [MeSH]
*Paroxetine: A serotonin uptake inhibitor that is effective in the treatment of depression. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belle, DJ; Ernest, CS; Sauer, JM; Smith, BP; Thomasson, HR; Witcher, JW | 1 |
1 trial(s) available for camostat and paroxetine
| Article | Year |
|---|---|
Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics.
Topics: Administration, Oral; Adult; Area Under Curve; Atomoxetine Hydrochloride; Blood Pressure; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Female; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Phenols; Phenyl Ethers; Propylamines; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Symporters; Time Factors | 2002 |